167 related articles for article (PubMed ID: 7858851)
1. The haemodynamic actions of ZENECA ZD7288, a novel sino-atrial node function modulator, in the exercising beagle: a comparison with zatebradine and propranolol.
Rouse W; Stafford PJ; Johnson IR
Br J Pharmacol; 1994 Nov; 113(3):1071-7. PubMed ID: 7858851
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic actions of a novel sino-atrial node function modulator, ZENECA ZD7288, in the anaesthetized dog: a comparison with zatebradine, atenolol and nitrendipine.
Rouse W; Johnson IR
Br J Pharmacol; 1994 Nov; 113(3):1064-70. PubMed ID: 7858850
[TBL] [Abstract][Full Text] [Related]
3. I(f) current mediates beta-adrenergic enhancement of heart rate but not contractility in vivo.
Guth BD; Dietze T
Basic Res Cardiol; 1995; 90(3):192-202. PubMed ID: 7575372
[TBL] [Abstract][Full Text] [Related]
4. Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on guinea pig sinoatrial node and ventricular action potentials.
Briggs I; BoSmith RE; Heapy CG
J Cardiovasc Pharmacol; 1994 Sep; 24(3):380-7. PubMed ID: 7528293
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells.
BoSmith RE; Briggs I; Sturgess NC
Br J Pharmacol; 1993 Sep; 110(1):343-9. PubMed ID: 7693281
[TBL] [Abstract][Full Text] [Related]
6. Role of zatebradine and propranolol in attenuation of tachycardia produced by dobutamine in pigs.
Neustein SM; Dimich I; Shiang H; Mezrow C
Acta Anaesthesiol Scand; 1997 Aug; 41(7):849-52. PubMed ID: 9265927
[TBL] [Abstract][Full Text] [Related]
7. ICI D7288, a novel sinoatrial node modulator.
Marshall PW; Rouse W; Briggs I; Hargreaves RB; Mills SD; McLoughlin BJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):902-6. PubMed ID: 7687714
[TBL] [Abstract][Full Text] [Related]
8. Increases in inotropic state without change in heart rate: combined use of dobutamine and zatebradine in conscious dogs.
Hettrick DA; Pagel PS; Lowe D; Tessmer JP; Warltier DC
Eur J Pharmacol; 1996 Dec; 316(2-3):237-44. PubMed ID: 8982692
[TBL] [Abstract][Full Text] [Related]
9. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
Simon L; Ghaleh B; Puybasset L; Giudicelli JF; Berdeaux A
J Pharmacol Exp Ther; 1995 Nov; 275(2):659-66. PubMed ID: 7473152
[TBL] [Abstract][Full Text] [Related]
10. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
Krumpl G; Winkler M; Schneider W; Raberger G
Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
[TBL] [Abstract][Full Text] [Related]
13. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
14. Beta adrenergic blockade with propranolol and atenolol in the exercising dog: evidence for beta 2 adrenoceptors in the sinoatrial node.
Friedman DB; Musch TI; Williams RS; Ordway GA
Cardiovasc Res; 1987 Feb; 21(2):124-9. PubMed ID: 2822246
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475
[TBL] [Abstract][Full Text] [Related]
16. Effect of zatebradine on contractility, relaxation and coronary blood flow.
Breall JA; Watanabe J; Grossman W
J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013
[TBL] [Abstract][Full Text] [Related]
17. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.
Furukawa Y; Nakano H; Oguchi T; Kasama M; Hoyano Y; Chiba S
J Pharmacol Exp Ther; 1995 Feb; 272(2):744-9. PubMed ID: 7853189
[TBL] [Abstract][Full Text] [Related]
19. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
20. Effects of a sinus node inhibitor on the normal and failing rabbit heart.
Ryu KH; Tanaka N; Ross J
Basic Res Cardiol; 1996; 91(2):131-9. PubMed ID: 8740529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
